Reviews in Endocrine & Metabolic Disorders

Papers
(The TQCC of Reviews in Endocrine & Metabolic Disorders is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Multidisciplinary management of acromegaly: A consensus182
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis138
Impact of COVID-19 on the thyroid gland: an update133
Endocrine and metabolic aspects of the COVID-19 pandemic107
Vitamin D, infections and immunity106
The role of the Mediterranean diet on weight loss and obesity-related diseases77
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?76
Hormonal treatments for endometriosis: The endocrine background74
The endocrine role of brown adipose tissue: An update on actors and actions72
New aspects in the pathogenesis and management of subacute thyroiditis67
Leptin as a key regulator of the adipose organ61
COVID-19 and diabetes mellitus: how one pandemic worsens the other57
Protein, amino acids and obesity treatment56
Diet approach before and after bariatric surgery55
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications53
The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis52
Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature47
Association of vitamin D status with COVID-19 and its severity45
Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases44
Double burden of malnutrition in persons with obesity40
Mammary gland adipocytes in lactation cycle, obesity and breast cancer39
Lean NAFLD: an underrecognized and challenging disorder in medicine39
Clinical manifestations and management of fatty acid oxidation disorders37
The epidemiology of aggressive pituitary tumors (and its challenges)36
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes35
ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity35
Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis35
Polyphenols and their anti-obesity role mediated by the gut microbiota: a comprehensive review33
Ketogenic diets as treatment of obesity and type 2 diabetes mellitus31
Classification of neuroendocrine neoplasms: lights and shadows31
Acromegaly, inflammation and cardiovascular disease: a review31
Glucocorticoid excess and COVID-19 disease31
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer31
Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects30
Thyroid sequelae of COVID-19: a systematic review of reviews30
Intercellular and interorgan crosstalk through adipocyte extracellular vesicles29
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions28
Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism27
Microbiome response to diet: focus on obesity and related diseases27
Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges27
Laron syndrome – A historical perspective26
Growth hormone and aging25
Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review25
Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta-analysis24
Vitamin D regulation of immune function during covid-1924
Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation24
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure24
Current concepts of the diagnosis of adult growth hormone deficiency24
Future lines of research on phase angle: Strengths and limitations23
Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome23
Paediatric Cushing’s disease: Epidemiology, pathogenesis, clinical management and outcome22
"Present and future of immunotherapy in Neuroendocrine Tumors"22
Mechanisms linking obesity and its metabolic comorbidities with cerebral grey and white matter changes22
Novel insights into adipose tissue heterogeneity22
The experiences of pregnant women with gestational diabetes mellitus: a systematic review of qualitative evidence21
Phase angle and cellular health: inflammation and oxidative damage21
Can conditions of skeletal muscle loss be improved by combining exercise with anabolic–androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions21
Obesity, type 2 diabetes, and testosterone in ageing men20
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective20
Interactions between emotions and eating behaviors: Main issues, neuroimaging contributions, and innovative preventive or corrective strategies20
Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?20
Shifts in gut microbiota and their metabolites induced by bariatric surgery. Impact of factors shaping gut microbiota on bariatric surgery outcomes20
AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance19
A systematic review of resting-state functional connectivity in obesity: Refining current neurobiological frameworks and methodological considerations moving forward19
Growth hormone deficiency and replacement therapy in adults: Impact on survival19
Education-based, lifestyle intervention programs with unsupervised exercise improve outcomes in adults with metabolic syndrome. A systematic review and meta-analysis19
Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives19
How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health18
Sleep, testosterone and cortisol balance, and ageing men18
Role of phase angle in older adults with focus on the geriatric syndromes sarcopenia and frailty18
Beta-klotho in type 2 diabetes mellitus: From pathophysiology to therapeutic strategies18
Relevance of body composition in phenotyping the obesities18
Expected and paradoxical effects of obesity on cancer treatment response18
Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?17
Dietary weight-loss interventions for the management of obesity in older adults17
Zinc-alpha2-glycoprotein, dysglycaemia and insulin resistance: a systematic review and meta-analysis17
Effect of resistance training on bioelectrical phase angle in older adults: a systematic review with Meta-analysis of randomized controlled trials17
The role of testosterone in male sexual function17
Food cue reactivity: Neurobiological and behavioral underpinnings17
COVID-19 and hypopituitarism17
The TWEAK/Fn14/CD163 axis—implications for metabolic disease17
Leptin, the brain and energy homeostasis: From an apparently simple to a highly complex neuronal system16
Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment – A Review16
Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults16
Pasireotide—a novel somatostatin receptor ligand after 20 years of use16
Deep neural network for food image classification and nutrient identification: A systematic review16
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease16
The role of dietary protein in obesity16
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?16
The effects of cannabis and cannabinoids on the endocrine system16
Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention16
0.072103023529053